1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Eyegate Pharmaceuticals Inc (EYEG)
  7. Quote


Eyegate Pharmaceuticals Stock Price

0.08 (4.1%)
Volume 1,159,608
Bid Price 2.00
Ask Price 2.03
News (1)
Day High 2.05


52 Week Range


Day Low 1.90
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Eyegate Pharmaceuticals Inc EYEG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.08 4.1% 2.03 18:04:24
Open Price Low Price High Price Close Price Prev Close
1.98 1.90 2.05 2.03 1.95
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,575 1,159,608 $ 1.99 $ 2,309,593 - 1.44 - 8.135
Last Trade Time Type Quantity Stock Price Currency
18:04:24 formt 1,000 $ 2.03 USD


Draw Mode:

Eyegate Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 25.62M 12.62M 9.15M $ 12.06k $ - -1.77 -1.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -2.47M 8.50%

more financials information »

Eyegate Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EYEG Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.922.191.801.961,075,7410.115.73%
1 Month1.942.341.732.032,081,0570.094.64%
3 Months2.412.801.441.921,975,233-0.38-15.77%
6 Months4.456.431.442.531,423,492-2.42-54.38%
1 Year3.778.1351.443.17932,260-1.74-46.15%
3 Years0.29513.49950.152.72515,2561.74588.14%
5 Years1.6313.49950.152.10540,1220.4024.54%

Eyegate Pharmaceuticals Description

Eyegate Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The company's lead product EGP-437 incorporates a reformulated topically active corticosteroid, Dexamethasone Phosphate, that is delivered into the ocular tissues through a proprietary drug delivery system, the EyeGate II Delivery System. It mainly develops EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and ciliary body.

Your Recent History
Eyegate Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.